About
Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.
Key Metrics
as of Sep 2026Market Cap60 Cr
P/Eβ
Div Yield0.00 %
Book ValueβΉ-1.02
52w HighβΉ53.80
52w LowβΉ6.75
Face ValueβΉ5.00
Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.67 | 0.72 | 0.35 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.79 | 0.78 | 0.47 | 0.23 | 0.04 | 0.04 | 0.02 | 0.07 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Operating Profit | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| OPM % | -17.91 | -8.33 | -34.29 | -15.00 | β | β | β | β | β | β | β | β | β |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Tax % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | β | β | β | 0.00 | β |
| Net Profit | -0.12 | -0.06 | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS in Rs | -0.10 | -0.05 | -0.10 | -0.02 | -0.03 | -0.03 | -0.02 | -0.06 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.27 | 0.00 | 0.00 | 0.00 | -0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.03 | 0.08 |
| Expenses | 1.52 | 0.14 | 0.02 | 0.00 | 0.04 | 0.06 | 0.15 | 0.10 | 0.05 | 0.12 | 0.03 | 0.05 |
| Operating Profit | -0.25 | -0.14 | -0.02 | 0.00 | -0.08 | -0.06 | -0.15 | -0.10 | -0.05 | -0.06 | 0.00 | 0.03 |
| OPM % | -19.69 | β | β | β | β | β | β | β | β | -100.00 | 0.00 | 37.50 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.25 | -0.14 | -0.02 | 0.00 | -0.08 | -0.06 | 0.00 | -0.08 | -0.02 | -0.06 | 0.00 | 0.03 |
| Tax % | 0.00 | 0.00 | 0.00 | β | 0.00 | 0.00 | β | 0.00 | 0.00 | 0.00 | β | 33.33 |
| Net Profit | -0.25 | -0.14 | -0.02 | 0.00 | -0.08 | -0.06 | 0.00 | -0.08 | -0.02 | -0.06 | 0.00 | 0.02 |
| EPS in Rs | -0.21 | -0.12 | -0.02 | 0.00 | -0.07 | -0.05 | 0.00 | -0.07 | -0.02 | -0.05 | 0.00 | 0.02 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | β | 0.00 | 0.00 | β | 0.00 | 0.00 | 0.00 | β | 0.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Reserves | -4.24 | -3.35 | -3.21 | -3.00 | -3.00 | -2.92 | -2.86 | -2.61 | -2.53 | -2.51 | -2.45 | -2.33 |
| Borrowings | 1.47 | 0.25 | 0.04 | 0.08 | 0.00 | 0.00 | 0.00 | 0.21 | 0.17 | 0.01 | 0.01 | 0.00 |
| Other Liabilities | 0.95 | 0.12 | 0.17 | 0.11 | 0.18 | 0.15 | 0.13 | 0.19 | 0.14 | 0.13 | 0.09 | 0.09 |
| Total Liabilities | 1.19 | 0.03 | 0.01 | 0.20 | 0.19 | 0.24 | 0.28 | 0.80 | 0.79 | 0.64 | 0.66 | 0.77 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.27 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Other Assets | 1.19 | 0.03 | 0.01 | 0.00 | -0.01 | 0.04 | 0.08 | 0.60 | 0.59 | 0.44 | 0.46 | 0.45 |
| Total Assets | 1.19 | 0.03 | 0.01 | 0.20 | 0.19 | 0.24 | 0.28 | 0.80 | 0.79 | 0.64 | 0.66 | 0.77 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.59 | -0.19 | -0.01 | 0.01 | -0.04 | -0.01 | -0.01 | -0.02 | 0.01 | -0.04 | -0.02 | -0.01 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | -0.07 | 0.07 | 0.02 | 0.01 |
| Cash from Financing Activity | 0.58 | 0.21 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.16 | 0.00 | 0.01 | 0.00 |
| Net Cash Flow | -0.01 | 0.02 | 0.00 | 0.01 | 0.00 | -0.01 | -0.01 | 0.01 | 0.10 | 0.03 | 0.00 | 0.00 |
| Free Cash Flow | -0.59 | -0.19 | -0.01 | 0.01 | -0.04 | -0.01 | -0.01 | -0.02 | 0.01 | -0.04 | -0.02 | -0.01 |
| CFO/OP % | 236.00 | 136.00 | 50.00 | β | 50.00 | 17.00 | 7.00 | 20.00 | -20.00 | 67.00 | β | -33.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | β | 0.00 | β | β | β | 1,703.33 | 3,041.67 | 1,003.75 |
| Inventory Days | 0.00 | β | 0.00 | β | β | β | β | β | β |
| Cash Conversion Cycle | 0.00 | β | 0.00 | β | β | β | 1,703.33 | 3,041.67 | 1,003.75 |
| Working Capital Days | -106.34 | β | -1,642.50 | β | β | β | 1,460.00 | 4,015.00 | 1,460.00 |
| ROCE % | -333.33 | 0.00 | -160.00 | -50.00 | -12.70 | -3.45 | -11.11 | 0.00 | 4.51 |
Corporate Actions
1 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Split | 30 Apr 2014 | 02 May 2014 | 10:5 | β |